MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517009870 A) filed by Mindset Pharma Inc., Toronto, on Feb. 6, for '3-pyrrolidine-indole dimers as serotonergic agents useful for the treatment of disorders related thereto.'
Inventor(s) include Slassi, Abdelmalik; and Araujo, Joseph A.
The application for the patent was published on April 18, under issue no. 16/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to 3-cyclic amine-indole dimers of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disord...